News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Patricia Ortega Muñoz
#NewAseBioMember | “AseBio is the meeting point for all companies that aim to contribute to science through the biotechnology sector”
Healthcare · Corporate
Meet our new member MedBioinformatics. We sponke with Patricia Ortega Muñoz, CEO and Medical…
AseBio - MEISYS
Prevención versus Terapia. El gran avance del siglo actual
Prevention versus Therapy. The breakthrough of the current century
Healthcare
Massive data collection accelerated by the digitisation of healthcare, as well as artificial…
Partners - GENESIS Biomed
Conferencia Anual Plataformas Tecnológicas Investigación Biomédica
Biomedical innovation 'made in Spain': Challenges and opportunities in the long race to market
Healthcare · Access to innovation · Financing
Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research…
Edificio Oryzon
ORYZON awarded 13.26 million € through the first Important Project of Common European Interest (IPCEI) in the health sector (Med4Cure project)
Healthcare · Rare diseases · Innovative drugs
Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and…
Partners - Oryzon Genomics
Científicos analizando muestras en un laboratorio
Theriva™ Biologics Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE Phase 2b Clinical Trial of VCN-01 with Gemcitabine/nab-Paclitaxel in Newly-Diagnosed Metastatic Pancreatic Cancer Patients
Healthcare · Access to innovation · Innovative drugs
Patients treated with VCN-01 (zabilugene almadenorepvec) plus gemcitabine/nab-paclitaxel standard-…
Oficinas de la compañía biotech Natac
Natac closes 2024 with record sales of nearly 36 million euros
Corporate
The company increased its normalized EBITDA by 47%, reaching €13.82 million.
Partners - Natac Group
Ferran Headshot socio fundador
#NewAseBioMember | "We believe that AseBio can serve as an important tool for expanding collaborations"
Healthcare · Corporate
Meet our new member MedBioinformatics. We sponke with Ferran Sanz, Founding Partner, Member of the…
AseBio - MEDBIOINFORMATICS SOLUTIONS
CEOs de las empresas Nuage Therapeutics, Ona Therapeutics y SpliceBio
Nuage Therapeutics, Ona Therapeutics, and SpliceBio are leading the wave of biotech innovation in Barcelona
Healthcare · Rare diseases · Personalized medicine · Advanced therapies
Las biotecnológicas Nuage Therapeutics, Ona Therapeutics y SpliceBio, con sede en el Parque…
Partners - Parc Científic de Barcelona
Thumbnail
John Nicols joins ZYMVOL’s board of directors
Corporate
Partners - Zymvol Biomodeling